- Home
- SAGE vs EBF Comparison
SAGE vs EBF Comparison
Compare SAGE & EBF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SAGE
- EBF
- Stock Information
- Founded
- SAGE 2010
- EBF 1909
- Country
- SAGE United States
- EBF United States
- Employees
- SAGE N/A
- EBF N/A
- Industry
- SAGE Biotechnology: Pharmaceutical Preparations
- EBF Office Equipment/Supplies/Services
- Sector
- SAGE Health Care
- EBF Consumer Discretionary
- Exchange
- SAGE Nasdaq
- EBF Nasdaq
- Market Cap
- SAGE 474.6M
- EBF 551.3M
- IPO Year
- SAGE 2014
- EBF N/A
- Fundamental
- Price
- SAGE $7.37
- EBF $19.86
- Analyst Decision
- SAGE Hold
- EBF
- Analyst Count
- SAGE 19
- EBF 0
- Target Price
- SAGE $9.88
- EBF N/A
- AVG Volume (30 Days)
- SAGE 1.2M
- EBF 272.2K
- Earning Date
- SAGE 04-24-2025
- EBF 04-21-2025
- Dividend Yield
- SAGE N/A
- EBF 5.04%
- EPS Growth
- SAGE N/A
- EBF N/A
- EPS
- SAGE N/A
- EBF 1.58
- Revenue
- SAGE $41,243,000.00
- EBF $399,351,000.00
- Revenue This Year
- SAGE $100.39
- EBF N/A
- Revenue Next Year
- SAGE $70.86
- EBF N/A
- P/E Ratio
- SAGE N/A
- EBF $12.80
- Revenue Growth
- SAGE N/A
- EBF N/A
- 52 Week Low
- SAGE $4.62
- EBF $18.88
- 52 Week High
- SAGE $17.51
- EBF $25.75
- Technical
- Relative Strength Index (RSI)
- SAGE 40.58
- EBF 39.43
- Support Level
- SAGE $7.99
- EBF $19.35
- Resistance Level
- SAGE $7.97
- EBF $20.55
- Average True Range (ATR)
- SAGE 0.31
- EBF 0.47
- MACD
- SAGE -0.10
- EBF -0.06
- Stochastic Oscillator
- SAGE 1.37
- EBF 23.83
About SAGE Sage Therapeutics Inc.
Sage Therapeutics Inc is a clinical-stage biopharmaceutical company focused on brain health medicines. The company is targeting diseases and disorders of the brain with three key focus areas: depression, neurology and neuropsychiatry; also targeting two critical central nervous system, or CNS, receptor systems, GABA and NMDA. Its products ZURZUVAE is a medicine for the treatment of postpartum depression, or PPD, in adults, and ZULRESSO is a CIV injection for the treatment of postpartum depression in individuals 15 years old and older. It also has other drugs in its pipeline such as SAGE-324, Dalzanemdor (SAGE-718) among others.
About EBF Ennis Inc.
Ennis Inc is a manufacturer and supplier of print products for the wholesale trade. The company's products include advertising specialities, business forms and supplies, commercial printing, eCommerce solutions, envelopes, labels and tags, and folders and packaging. Its products include snap sets, continuous forms, laser cut sheets, tags, labels, envelopes, integrated products, jumbo rolls, and pressure-sensitive products in short, medium and long runs under the following labels: Ennis, Royal Business Forms, Block Graphics, 360º Custom LabelsSM, ColorWorx, Enfusion, among others.